Wall Street’s Key Stock Analysts Research Report

Wall Street’s Key Stock Analysts Research Report

$APLT, $BIIB, $GILD, $LOGI, $STNE

Daily HeffX-LTN reviews dozens of  Wall Street’s Key analysts research reports to ID new trading and investing ideas for HeffX-LTN readers. Some reports cover stocks to buy, and others cover stocks to sell or avoid.

Below is the list for Friday, 28 February, as follows;

Applied Therapeutics Inc. (NASDAQ:APLT) was started with an Overweight rating and a 64 target price at Barclays. Its consensus target price was 50.67.

Biogen Inc. (NASDAQ:BIIB) was started with an Overweight rating and a 389 target price at Barclays.

Gilead Sciences Inc. (NASDAQ:GILD) was started with an Underweight rating and a 62 target price at Barclays. The stock closed up over 6% at 74.70 Wednesday, after starting trials here in the US to see if its drug can help cure the coronavirus. Shares finished at 72.66 Thursday.

Logitech International S.A. (NASDAQ:LOGI) was raised to Overweight from Neutral with a 48 target price at JPMorgan. Shares have consensus target price was 54.20.

StoneCo. Ltd. (NASDAQ:STNE) was raised to Overweight from Neutral and its target price was raised to 48 from 43 at JPMorgan. The 52-wk trading range is 23.15 – 45.72.

Have a terrific weekend

  

The following two tabs change content below.
HEFFX has become one of Asia’s leading financial services companies with interests in Publishing, Private Equity, Capital Markets, Mining, Retail, Transport and Agriculture that span every continent of the world. Our clearing partners have unprecedented experience in Equities, Options, Forex and Commodities brokering, banking, physical metals dealing, floor brokering and trading.

Latest posts by HEFFX Australia (see all)